Chantix, a popular aid used to quit smoking, may increase your chances of a heart attack and depression.
A vaccine that could help people stop smoking is showing promise in early clinical trials, researchers announced this week at a national meeting of addiction specialists.
"Look, we had some great times together and a lot of fun," Natasha Bishop said. "But now I feel we are moving in different directions and I need to end this relationship."
Two popular anti-smoking drugs will now carry warnings about the risk of severe mental health problems, the Food and Drug Administration announced Wednesday.
I quit smoking two months ago with the help of Chantix. However, I seem to cough more now than than when I was smoking. Is this normal for people who have smoked for 20 years? I feel much better overall, but I am a little concerned that maybe emphysema might be setting in.
Smoking is bad for you, and by now, most of us know it.
The federal government's new advice to doctors for helping
smokers quit recommends the drug Chantix, which has recently been
linked with depression and suicidal behavior
Two years ago, scientists had high hopes for new pills that would
help people quit smoking, lose weight and maybe kick other tough
addictions like alcohol and cocaine
For millions of frustrated smokers, drugmakers promise to help them quit with a little pill. But studies from the companies themselves don't show very promising results.
Pfizer Inc.'s chief executive Jeffrey Kindler on Wednesday dismissed the idea that the drugmaker will go after any big acquisitions, because they're "disruptive" he said.
A flood of drug safety warnings from the Food and Drug Administration may have physicians and patients suffocating from information saturation. Experts say there are too many red flags for them to pay attention.
U.S. stocks leaned lower at the start of trading Monday as investors considered the weakened economy and a possible battle over Yahoo.
It's been hard for Pfizer, the world's largest drugmaker, to catch a break lately.
Any smoker knows what a bummer it is to quit, but Pfizer's new smoking cessation drug may trigger depression or suicidal thoughts, the Food and Drug Administration said today.
Avandia is getting a black box warning from the FDA. CNN's Dr. Sanjay Gupta explains.
Researchers are constantly searching for ways to help people quit. What's new? Here are four strategies worth a try:
A single pill appears to hold promise in curbing the urges to both smoke and drink, according to researchers trying to help people overcome addiction by targeting a pleasure center in the brain
The Food and Drug Administration approved Chantix, the smoking cessation drug from Pfizer.
© 2013 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
|